InsiderTrades.com logo
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

SNG Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £1,173.69
Insider Selling (Last 12 Months): GBX 0

Synairgen Insider Trading History Chart

This chart shows the insider buying and selling history at Synairgen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Synairgen Share Price & Price History

Current Price: GBX 18.47
Price Change: ▲ Price Increase of +1.96 (11.88%)
As of 10/6/2022 01:00 AM ET

This chart shows the closing price history over time for SNG up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
In 20 years, this little-known trader didn’t have a single losing year…
From Legacy Research   |   Ad
In his debut video, Market Wizard Larry Benedict reveals how to make all the money you need, in any market, using a single stock. Click here to watch the video and get the name and ticker of the one stock that could put you on the road to financial success.
Click here to learn more.

Synairgen Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/27/2022Bruce CampbellInsiderBuy621GBX 189£1,173.69
8/12/2021John C WardInsiderSell269,963GBX 140£377,948.20
See Full Table
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast
From Legacy Research   |   Ad
He predicted the 2020 crash a month before it happened…He predicted this year’s collapse back in January…

And now, he’s issuing a brand-new warning – along with a unique solution.
Details here.

SEC Filings (Institutional Ownership Changes) for Synairgen (LON:SNG)

Synairgen logo
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.
Read More on Synairgen

Today's Range

Now: GBX 18.47
Low: 16.40
High: 19.70

50 Day Range

MA: GBX 22.40
Low: 16.15
High: 28.56

52 Week Range

Now: GBX 18.47
Low: 10
High: 223.80

Volume

858,254 shs

Average Volume

2,543,976 shs

Market Capitalization

£37.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Synairgen?

Synairgen's top insider investors include:
  1. Bruce Campbell (Insider)
  2. John C Ward (Insider)
Learn More about top insider investors at Synairgen.
The Last Great Value Stock
From Oxford Club   |   Ad
Last year it was more profitable than Disney, Square or even Tesla. But it's just under $2 per share.

This company's unusual business model has created a rare situation where it is both cheap and highly profitable, but it may not be $2 for long.

Check out the free presentation by clicking here.
>>>
pixel